Acute kidney injury and hemolytic anemia induced by rifampin, an infrequent and deadly complication

Abstract

Rifampicin is a widely used drug for the treatment of various infectious diseases with a broad spectrum of adverse reaction ranging from mild to life-threatening manifestations; hemolytic anemia is an adverse effect rarely reported in the literature, but it can have a potentially fatal outcome. Thus, we report a case of autoimmune hemolytic anemia associated with acute kidney injury in a young patient in the second phase of treatment for pulmonary tuberculosis.

Keywords

• acute kidney injury
• hemolysis
• rifampin